TABLE 1.

Characteristics of the study groups after randomisation

	Group A	Group B	Group C
Patients n	17	15	20
Age years, mean±sd	23.6±8.5	26.1±11.9	22.3±7.4
Female %	45	50	40
Controlled asthma n	9	7	12
Partially controlled asthma n	8	8	8
Asthma therapy n
SABA+ICS	9	8	10
LABA+ICS	8	7	10
ICS daily dose of budesonide µg, mean±sd	650±150	550±250	600±200
Time since diagnosis of asthma years, mean±sd	6±4.7	5.2±3.5	7.2±2.4
Allergic rhinitis n	11	10	12

SABA: short-acting β-agonist; LABA: long-acting β-agonist; ICS: inhaled glucocorticosteroids.